Connection

James Bearden to Alemtuzumab

Back to Details
This is a "connection" page, showing publications James Bearden has written about Alemtuzumab.
James Bearden
Connection Strength
0.019
Alemtuzumab
  1. Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase 2 trial of the Minnie Pearl Cancer Research Network. Cancer. 2008 Mar 15; 112(6):1288-95.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.